Accès ouvert
2025
erratum
OpenAlex
Yijing Chen, Fang Chen, Zhongzhong Chen, Yi-Chen Cathy Huang et autres
[This corrects the article DOI: 10.3389/fped.2024.1409264.].
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Yalun Li, Jin Zhou, Li Jiang, Hua Xie et autres
ABSTRACT In this Phase II study, 13 patients with stage IIIB/IV non‐small cell lung cancer with acquired resistance to immune checkpoint inhibitors were treated with tislelizumab, sitravatinib, and docetaxel. The efficacy and safety were evaluated. The combination treatment achieved median progression‐free survival …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Chenxiang Ding, Ruoyu Yao, Yong Wang, Hongjie Liu et autres
Colorectal cancer (CRC) is a threat to public health, with a global incidence and mortality of over 1.9 million and 0.9 million people, respectively. Anti-epidermal growth factor receptor (EGFR)-based treatment is recommended for CRC with wild-type rat sarcoma (RAS). However, after continuous …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Liang Zeng, Fan Tong, Xingxiang Xu, Lianxi Song et autres
cn, hk
(code pays fourni par la source)
2025
article
OpenAlex
Ruyi Zhang, Hua Xie, Zhongxian Zhu, Weibing Tang
BACKGROUND: Preemptive analgesia is an antinociceptive intervention aimed at inhibiting hyperexcitability in both the peripheral and central nervous systems, diminishing the intensity of postoperative pain. Pre-analgesic acetaminophen has been employed extensively in diverse surgical procedures among adult individuals; however, its efficacy in …
cn
(code pays fourni par la source)
2025
article
OpenAlex
YiWei Fang, Dan Yang, Ning Sun, Hongcheng Song et autres
cn
(code pays fourni par la source)
2025
article
OpenAlex
Yan Chen, Gang Wang, Yichen Huang, Yiqing Lyu et autres
Accès ouvert
2025
article
OpenAlex
Dong Bing Zhao, Minghong Bi, Xiaofei Cheng, Shuhong Wang et autres
Objective Camrelizumab, a programmed death-1 inhibitor, is effective and safe for treating patients with advanced lung cancer according to previous phase 3 trials. However, relevant real-world clinical evidence is required. This study intended to explore the efficacy and safety of camrelizumab-based therapies …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Yiwei Zhuang, Shuyi Wang, Hua Xie, Wei Qing et autres
ABSTRACT In this paper, we present an Augmented Reality (AR)‐based application combined with a robotic system for percutaneous renal puncture navigation interaction and demonstrate its technical feasibility. Our system provides an intuitive interaction scheme between the surgeon and the robot without the …
cn
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Yiwei Zhuang, Shuyi Wang, Hua Xie, Wei Qing et autres
In this paper, we present an Augmented Reality (AR)-based application combined with a robotic system for percutaneous renal puncture navigation interaction and demonstrate its technical feasibility. Our system provides an intuitive interaction scheme between the surgeon and the robot without the need …
cn
(code pays fourni par la source)
2024
article
OpenAlex
Changgui Lu, Hua Xie, Zhongxian Zhu, Zequan Ding et autres
cn
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Mingming Yu, Hua Xie, Yi-Chen Cathy Huang, Yiqing Lv et autres
This study aimed to investigate the incidence of patent processus vaginalis (PPV) in pediatric patients with a unilateral nonpalpable testis and explore the associated factors. From May 2014 to April 2017, 152 boys who were diagnosed with a unilateral nonpalpable testis and …
cn
(code pays fourni par la source)